Research

Part of offering the best care is offering the latest care. Park Nicollet Heart and Vascular Center stays current and helps develop new and innovative drug therapies, methods of treating heart disease and new medical technologies by participating in national clinical research trials. Heart and Vascular Center doctors have actively participated in clinical and outcomes research for more than 20 years.

Find out how to participate

Research relationships

• 3M Pharmaceuticals
• Alexion
• AstraZeneca
• Bristol-Myers Squibb Company
• Celgene
• Celleration
• Cleveland Clinic
• Corgentech
• Eli Lilly and Company
• Kinetic Concepts Inc
• Mayo Physician Alliance for Clinical Trials
• Medtronic Inc.
• Merck & Co. Inc.
• National Institutes of Health
• Otuska Maryland Research Institute
• Outcome Sciences
• Proctor & Gamble
• Schering-Plough
• Scios
• TIMI Group from Harvard
• University of Minnesota
• Yamanouchi Pharma America Inc.

Current studies

PREFER study - comparing home pacemaker monitoring systems

24-hour Holter monitor study – collecting data about signal quality and arrhythmia detections through the use of continuous 24-hour Holter monitoring

Improve It study – comparing two anti-lipid medications in preventing complications in patients with Acute Coronary Syndrome.

See list of past studies

Published research

Park Nicollet Heart and Vascular doctors contribute to research, education and innovation by publishing their findings in peer-reviewed journals and books.

Jackson Thatcher, MD - Improved efficiency in acute myocardial infarction care through commitment to emergency department-initiated primary PCI, Journal of Invasive Cardiology. Dec 2003; 15(12):693-698.